EUVIMEDEUVIMED entdecken
Open Access

Clinicopathologic Features of Eyelid Sebaceous Gland Carcinoma Requiring Immunohistochemical Diagnosis

Tatsuya Yunoki, Akio Miyakoshi, Atsushi Hayashi

Ocular Oncology and Pathology · 2024 · 10 (3) · 131-138

DOI: 10.1159/000538537 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ocular Oncology and Pathology, online erschienen am 29.04.2024. Verfasst von Tatsuya Yunoki und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The aim of the study was to evaluate the clinicopathological features of eyelid sebaceous gland carcinoma (SGC), which requires immunohistochemical examination for a definitive diagnosis.

Methods

Twenty-seven patients with a final diagnosis of eyelid SGC at Toyama University Hospital between April 2016 and April 2022 were retrospectively studied. In cases with a strong clinical suspicion of SGC, if the initial pathological diagnosis by hematoxylin-eosin staining was non-SGC, additional detailed pathology was performed, including immunostaining for adipophilin (ADP) and androgen receptor (AR).

Results

Five patients (18.5%) had a diagnosis other than SGC, including three with squamous cell carcinoma (SCC), one with basal cell carcinoma, and one with Bowen disease. In these 5 cases, detailed pathology, including immunostaining for ADP and AR, was performed again, which ultimately led to the diagnosis of SGC. ADP was positive in all 5 cases, and AR was positive in 4 cases. The 3 patients diagnosed with SCC were characterized by a high Ki-67 index, active mitosis, and relatively low differentiation.

Conclusion

SGC can be pathologically diagnosed in other cancers, such as SCC and BCC. When SCC was diagnosed, it was often hypo-differentiated and required more attention. Immunostaining for ADP and AR is invaluable for confirming SGC diagnosis.

Schlagwörter

Stichwörter der Autor:innen

AdipophilinAndrogen receptorSebaceous gland carcinoma

Autor:innen und Institutionen

  • Department of Ophthalmology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.

Zitieren

APA

Yunoki, T., Miyakoshi, A., & Hayashi, A. (2024). Clinicopathologic Features of Eyelid Sebaceous Gland Carcinoma Requiring Immunohistochemical Diagnosis. Ocular Oncology and Pathology, 10(3), 131-138. https://doi.org/10.1159/000538537

Vancouver

Yunoki T, Miyakoshi A, Hayashi A. Clinicopathologic Features of Eyelid Sebaceous Gland Carcinoma Requiring Immunohistochemical Diagnosis. Ocular Oncology and Pathology. 2024;10(3):131-138. doi:10.1159/000538537

BibTeX
@article{Yunoki2024,
  author = {Yunoki, Tatsuya and Miyakoshi, Akio and Hayashi, Atsushi},
  title = {Clinicopathologic Features of Eyelid Sebaceous Gland Carcinoma Requiring Immunohistochemical Diagnosis},
  journal = {Ocular Oncology and Pathology},
  year = {2024},
  volume = {10},
  number = {3},
  pages = {131--138},
  doi = {10.1159/000538537}
}
Kostenlos starten →